Analyst Activity – Shore Capital Reiterates Hold on GlaxoSmithKline plc (LON:GSK)

ME Staff
-
0

Analyst Ratings For GlaxoSmithKline plc (LON:GSK)

Today, Shore Capital reiterated its Hold rating on GlaxoSmithKline plc (LON:GSK).

There are 4 sell ratings, 10 hold ratings, 8 buy ratings on the stock.

The current consensus rating on GlaxoSmithKline plc (LON:GSK) is Hold (Score: 2.18) with a consensus target price of GBX 1,741.14 per share, a potential .

Some recent analyst ratings include

  • 7/28/2017-Shore Capital Reiterated Rating of Hold.
  • 7/27/2017-Credit Suisse Group Reiterated Rating of Neutral.
  • 7/27/2017-Kepler Capital Markets Reiterated Rating of Reduce.
  • 7/27/2017-Barclays PLC Reiterated Rating of Equal weight.
  • 7/27/2017-Liberum Capital Reiterated Rating of Buy.


    Recent Trading Activity for GlaxoSmithKline plc (LON:GSK)
    Shares of GlaxoSmithKline plc closed the previous trading session at 1,522.80 down -8.20 -0.54% with 9,355,119 shares trading hands.